Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis

Chin Neoh; Danny Liew; Monica Slavin; Debbie Marriott; Sharon Chen; Orla Morrissey; Kay Stewart; David Kong

doi:10.1093/jac/dkr186

Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis

Chin Neoh
, Danny Liew
, Monica Slavin
, Debbie Marriott
, Sharon Chen
, Orla Morrissey
, Kay Stewart
, David Kong

Research output: Contribution to journal › Article › Research › peer-review

26 Citations (Scopus)

Abstract

Anidulafungin was found to be non-inferior to and possibly more efficacious than fluconazole for treatment of invasive candidiasis (IC) in a major randomized clinical trial (RCT). There are no data comparing the cost-effectiveness between azoles and echinocandins in treating IC. This economic analysis investigated the cost-effectiveness of anidulafungin compared with fluconazole for treatment of IC in an Australian setting.

Original language	English
Pages (from-to)	1906-1915
Number of pages	10
Journal	Journal of Antimicrobial Chemotherapy
Volume	66
DOIs	https://doi.org/10.1093/jac/dkr186
Publication status	Published - 2011

Access to Document

10.1093/jac/dkr186

Cite this

@article{65e412fb0ebb4f4ebeb3f4574a8729cf,

title = "Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis",

abstract = "Anidulafungin was found to be non-inferior to and possibly more efficacious than fluconazole for treatment of invasive candidiasis (IC) in a major randomized clinical trial (RCT). There are no data comparing the cost-effectiveness between azoles and echinocandins in treating IC. This economic analysis investigated the cost-effectiveness of anidulafungin compared with fluconazole for treatment of IC in an Australian setting.",

author = "Chin Neoh and Danny Liew and Monica Slavin and Debbie Marriott and Sharon Chen and Orla Morrissey and Kay Stewart and David Kong",

year = "2011",

doi = "10.1093/jac/dkr186",

language = "English",

volume = "66",

pages = "1906--1915",

journal = "Journal of Antimicrobial Chemotherapy",

issn = "0305-7453",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis

AU - Neoh, Chin

AU - Liew, Danny

AU - Slavin, Monica

AU - Marriott, Debbie

AU - Chen, Sharon

AU - Morrissey, Orla

AU - Stewart, Kay

AU - Kong, David

PY - 2011

Y1 - 2011

N2 - Anidulafungin was found to be non-inferior to and possibly more efficacious than fluconazole for treatment of invasive candidiasis (IC) in a major randomized clinical trial (RCT). There are no data comparing the cost-effectiveness between azoles and echinocandins in treating IC. This economic analysis investigated the cost-effectiveness of anidulafungin compared with fluconazole for treatment of IC in an Australian setting.

AB - Anidulafungin was found to be non-inferior to and possibly more efficacious than fluconazole for treatment of invasive candidiasis (IC) in a major randomized clinical trial (RCT). There are no data comparing the cost-effectiveness between azoles and echinocandins in treating IC. This economic analysis investigated the cost-effectiveness of anidulafungin compared with fluconazole for treatment of IC in an Australian setting.

UR - http://jac.oxfordjournals.org/content/66/8/1906.full.pdf+html

U2 - 10.1093/jac/dkr186

DO - 10.1093/jac/dkr186

M3 - Article

SN - 0305-7453

VL - 66

SP - 1906

EP - 1915

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

ER -

Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis

Abstract

Access to Document

Other files and links

Research output

Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis

Cite this